5 results
10-K
2020 FY
BNTC
Benitec Biopharma Inc
23 Sep 20
Annual report
4:50pm
, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our … in the loss or disclosure of critical or sensitive data, which could result in financial, legal, business or reputational harm to us.
Our current laboratory
S-1
BNTC
Benitec Biopharma Inc
14 Aug 20
IPO registration
4:11pm
, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our … , which could result in financial, legal, business or reputational harm to us.
Our current laboratory operations are concentrated in one location and any
- Prev
- 1
- Next